Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New technique in permanent bradytherapy for the treatment of lung cancer

09.07.2004


The University Hospital at Navarre University has developed a system for the percutaneous implantation of palladium 103 seeds, a new technique in permanent bradytherapy for the treatment of lung cancer. Recently, the fourth experiment was carried out and the results remitted to the scientific magazine, "Bradytherapy", for its publication. To date there has been no description in world scientific literature of any case using this therapeutic procedure.



The Clínica Universitaria has hosted the only cases of bradytherapy using palladium implantation although, in the literature, there exist two articles on the treatment of 8 patients with iodine 125, a radioisotope especially suited to treatment of prostate cancer. In this case it was decided to opt for palladium 103 given that theoretically it adapts better to rapid and aggressive growth lesions such as the majority of primary lung tumours – although this affirmation is not backed up by clinical data. Apart from this, the isotope having a shorter half-life, the radiological protection measures are reduced.

Bradytherapy is a radical radiation technique which is undertaken jointly by the Radiology and Oncology Departments at the University Hospital. It involves the percutaneous implantation of radioactive seeds by means of vectors that are placed inside the tumour. The procedure is carried out under a general anaesthetic with the patient lying on their back. First, the radiologist selects the target area and then the vectors are introduced with the point guided by CAT (computer-controlled axial tomography); in this way the structures through which they pass can be seen in practically real time. Once it is confirmed that the vectors are correctly placed into position, the radioactive load is impanted.


Suitability

Bradytherapy with palladium 103 is suitable for those persons with small lesions which, because they are deemed medically unsuitable (because of age, accompanying illnesses, limited pulmonary capacity, etc.), cannot be subjected to open surgery involving the resection of lung tissue. They are very select, high-risk patients who have tumours accessible at the point of puncture by an external route. Until now, the only alternative therapy available to these patients has been external radiation. Nevertheless, this treatment has the drawback of lasting possibly weeks, whereas Bradytherapy is carried out in just one day.

The results obtained with this technique are very satisfactory although not definitive, given the short period of monitoring. Apart from these data, in the opinion of Dr. Martínez-Monge, Bradytherapy has demonstrated its success as a therapeutic option for this group of patients who cannot undergo surgery.

Given that the implantation of palladium 103 is carried out in a percutaneous manner, this technique provides the advantage of a rapid recovery without pain. Moreover, the only two possible complications (pneumothorax, i.e. entry of air into the thoracic cavity and the risk of bleeding) are verified in situ, which allows a rapid response. In any case, none of the patients treated with this procedure has shown these complications nor have others been observed.

Garazi Andonegi | Basque Research
Further information:
http://www.unav.es

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>